Alterations in specific gene expression and focal neoplastic growth during spontaneous hepatocarcinogenesis in albumin-SV40 T antigen transgenic rats

Molecular Carcinogenesis

Volumn 40, Issue 3, 2004, Pages 150-159

  Dragan, Yvonne P ^a   Sargen, Linda M ^b   Babcock, Karlee ^c   Kinunen, Nina ^c   Pitot, Henry C ^c  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^b NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Albumin SV40 transgenic rat; c myc; H19 gene expression; Hepatomas; Insulin growth factor 2

Indexed keywords

ALBUMIN; CYCLIN DEPENDENT KINASE INHIBITOR; GENE PRODUCT; HELIX LOOP HELIX PROTEIN; INSULIN; MESSENGER RNA; PROTEIN H19; PROTEIN KVLQT1; PROTEIN MASH2; PROTEIN P57; RIBONUCLEOTIDE REDUCTASE; RIBONUCLEOTIDE REDUCTASE M1; SOMATOMEDIN B; UNCLASSIFIED DRUG; VIRUS T ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASOPHIL; CANCER GROWTH; CHROMOSOME 11P; CHROMOSOME 1Q; CONTROLLED STUDY; ENHANCER REGION; FEMALE; GENE CLUSTER; GENE DUPLICATION; GENE EXPRESSION REGULATION; GENE LOCATION; GENOME IMPRINTING; GROWTH RATE; LIVER CANCER; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; LUNG NODULE; MALE; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SIMIAN VIRUS 40; SYNTENY; TRANSGENIC ANIMAL;

ALBUMINS; ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIGENS, POLYOMAVIRUS TRANSFORMING; CARCINOMA, HEPATOCELLULAR; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOME DELETION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MYC; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR II; LIVER NEOPLASMS, EXPERIMENTAL; MALE; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS C-MYC; RATS; RNA, MESSENGER;

ANIMALIA; SIMIAE; SIMIAN VIRUS 40;

EID: 3142673605     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/mc.20029     Document Type: Article

References (82)

1. Farber E. The step-by-step development of epithelial cancer: From phenotype to genotype. Adv Cancer Res 1996;70:21-48.
2. Drinkwater NR, Lee G-H. Genetic susceptibility to liver cancer. In: Jirtle R, editor. Liver regeneration and carcinogenesis. San Diego: Academic Press; 1995. pp 301-321.
3. Pitot HC, Dragan YP. Chemical induction of hepatic neoplasia. In: Arias I, Boyer J, Fausto N, Jakoby W, Schachter D, Shafritz D, editors. The liver; biology and pathobiology, 3rd edn. Hagerstown, MD: Raven Press; 1994. pp 1467-1495.
4. Pitot HC, Dragan YP, Teeguarden J, Hsia S, Campbell H. Quantitation of multistage carcinogenesis in rat liver. Toxicol Pathol 1996;24:119-128.
5. Dragan YP, Hully JR, Nakamura J, Mass MJ, Swenberg JA, Pitot HC. Biochemical events during initiation of rat hepatocarcinogenesis. Carcinogenesis 1994;15:1451-1458.
6. Pitot HC, Dragan YP. The multistage nature of chemically-induced hepatocarcinogenesis in the rat. Drug Metab Rev 1994;26:209-220.
7. Dragan YP, Sargent L, Xu Y-D, Xu Y-H, Pitot HC. The initiation-promotion- progression model of rat hepatocarcinogenesis. Proc Soc Exp Biol Med 1993;202:16-24.
8. Sargent L, Dragan Y, Xu Y-H, Sattler G, Wiley J, Pitot HC. Karyotypic changes in a multistage model of chemical hepatocarcinogenesis in the rat. Cancer Res 1996;56:2985-2991.
9. Hully JR, Su Y, Lohse JK, et al. Transgenic hepatocarcinogenesis in the rat. Am J Pathol 1994;145:384-397.
10. Sargent LM, Dragan YP, Sattler G, Xu Y-H, Wiley J, Pitot HC. Specific chromosomal changes in albumin simian virus 40 T antigen transgenic rat liver neoplasms. Cancer Res 1997;57:3451-3456.
11. Sargent L, Dragan YP, Babcock K, Wiley J, Klaunig J, Pitot HC. Cytogenetic analysis of three rat liver epithelial cell lines (WBneo, WBHa-ras, and WBraslla) and correlation of an early chromosomal alteration with insulin-like growth factor II expression. Cancer Res 1996;56:2992-2997.
12. Paulsen M, Davies KR, Bowden LM, et al. Syntenic organization of the mouse distal chromosome 7 imprinting cluster and the Beckwith-Wiedemann syndrome region in chromosome 11 p15.5. Hum Mol Genet 1998;7:1149-1159.
13. Poirier K, Chalas C, Tissier F, et al. Loss of parental-specific methylation at the IGF2 locus in human hepatocellular carcinoma. J Pathol 2003;201:473-479.
14. Schwienbacher C, Gramantieri L, Scelfo R, et al. Gain of imprinting at chromosome 11 p15: A pathogenetic mechanism identified in human hepatocarcinomas. Proc Natl Acad Sci USA 2000;97:5445-5449.
15. Fukuzawa R, Umezawa A, Ochi K, Urano F, Ikeda H, Hata J-I. High frequency of inactivation of the imprinted H19 gene in "sporadic" hepatoblastoma. Int J Cancer 1999;82:490-497.
16. Hsu S, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAH) procedures. J Histochem Cytochem 1981;29:577-580.
17. Campbell H, Xu Y, Hanigan M, Pitot H. Application of quantitative stereology to the evaluation of phenotypically heterogeneous enzyme-altered foci in the rat liver. J Natl Cancer Inst 1986;76:751-767.
18. Saltykov S. The determination of the size distribution of particles in an opaque material from measurement of the size distribution of their sections. In: Elias H, editor. Proceedings of the Second International Congress for Stereology. Berlin: Springer-Verlag; 1967. pp 163-173.
19. Delesse M. Procede mechanique pour determiner la composition des roches. Ann Mines 1848;13:379-388.
20. Squire RA, Levitt MH. Report of a workshop on classification of specific hepatocellular lesions in the rat. Cancer Res 1975;35:3214-3223.
21. Maronpot RR, Montgomery CA, Jr., Boorman GA, McConnell EE. National Toxicology Program nomenclature for hepatoproliferative lesions of rats. Toxicol Pathol 1986;14:263-273.
22. Chomzynski P, Sacchi N. Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
23. Oyamada M, Dempo K, Fujimoto Y, et al. Spontaneous occurrence of placental glutathione S-transferase-positive foci in the livers of LEC rats. Jpn J Cancer Res (Gann) 1988;79:5-8.
24. Satoh K, Kitahara A, Soma Y, Inaba Y, Hatayama I, Sato K. Purification, induction, and distribution of placental glutathione transferase: A new marker enzyme for preneoplastic cells in the rat chemical hepatocarcinogenesis. Proc Natl Acad Sci USA 1985;82:3964-3968.
25. Simmons DT. SV40 large T antigen functions in DNA replication and transformation. Adv Virus Res 2000;55:75-134.
26. Hermeking H, Wolf DA, Kohlhuber F, et al. Role of c-myc in simian virus 40 large tumor antigen-induced DNA synthesis in quiescent 3T3-L1 mouse fibroblasts. Proc Natl Acad Sci USA 1994;91:10412-10416.
27. Reik W, Walter J. Genomic imprinting: Parental influence on the genome: Nat Rev 2001;2:21-32.
28. Paulsen M, El-Maarri O, Engemann S, et al. Sequence conservation and variability of imprinting in the Beckwith-Wiedemann syndrome gene cluster in human and mouse. Hum Mol Genet 2000;9:1829-1841.
29. Caspary T, Cleary MA, Baker CC, Guan X-J, Tilghman SM. Multiple mechanisms regulate imprinting of the mouse distal chromosome 7 gene cluster. Mol Cell Biol 1998;18:3466-3474.
30. van Roozendaal CEP, Gillis AJM, Klijn JGM, et al. Loss of imprinting of IGF2 and not H19 in breast cancer, adjacent normal tissue, and derived fibroblast cultures. FEBS Lett 1998;437:107-111.
31. Adriaenssens E, Dumont L, Lottin S, et al. H19 overexpression in breast adenocarcinoma stroma cells is associated with tumor values and steroid receptor status but independent of p53 and Ki-67 expression. Am J Pathol 1998;153:1597-1607.
32. Soares MB, Turken A, Ishii D, et al. Rat insulin-like growth factor II gene. A single gene with two promoters expressing a multitranscript family. J Mol Biol 1986;192:737-752.
33. Muller S, van den Boom D, Zirkel D, et al. Retention of imprinting of the human apoptosis-related gene TSSC3 in human brain tumors. Hum Mol Genet 2000;22:757-763.
34. Rossant J, Guillemot F, Tanaka M, Latham K, Gertenstein M, Nagy A. Mash2 is expressed in oogenesis and preimplantation development but is not required for blastocyst formation. Mech Dev 1998;73:183-191.
35. Elford HL, Freese M, Passamani E, Morris HP. Ribonucleotide reductase and cell proliferation. J Biol Chem 1970;245:5228-5233.
36. Shirai T. A medium-term rat liver bioassay as a rapid in vivo test for carcinogenic potential: A historical review of model development and summary of results from 291 tests. Toxicol Pathol 1997;25:453-460.
37. Solt D, Farber E. New principle for the analysis of chemical carcinogenesis. Nature 1976;263:701-703.
38. Grippo PJ, Sandgren EP. Highly invasive transitional cell carcinoma of the bladder in a simian virus 40 T-antigen transgenic mouse model. Am J Pathol 2000;157:805-813.
39. Maroulakou IG, Anver M, Garrett L, Green JE. Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene. Proc Natl Acad Sci USA 1994;91:11236-11240.
40. Johnston SD, Liu X, Zuo F, et al. Estrogen-related receptor α1 functionally binds as a monomer to extended half site sequences including ones contained within estrogen-response elements. Mol Endocrinol 1997;11:342-352.
41. Matsuguchi T, Takahashi K, Ikejiri K, Ueno T, Endo H, Yamamoto M. Functional analysis of multiple promoters of the rat IGF II promoter. Biochim Biophys Acta 1990;1048:165-170.
42. Caricasole A, Ward A. Transactivation of mouse insulin-like growth factor II (IGF-II) gene promoters by the AP-1 complex. Nucleic Acids Res 1993;21:1873-1879.
43. Gaub M, Bellard M, Scheuer I, Chambon P, Sassone C. Activation of the estrogen receptor involves the fos-jun complex. Cell 1990;63:1267-1276.
44. Sáenz-Robles MT, Sullivan CS, Pipas JM. Transforming functions of simian virus 40. Oncogene 2001;20:7899-7907.
45. Simmons DT. SV40 large T antigen functions in DNA replication and transformation. Adv Virus Res 2000;55:75-134.
46. Deppert W, Steinmayer T, Richter W . Cooperation of SV40 large T antigen and the cellular protein p53 in maintenance of cell transformation. Oncogene 1989;4:1103-1110.
47. Fujimoto Y, Ishizaka Y, Tahira T, et al. Possible involvement of c-myc but not ras genes in hepatocellular carcinomas developing after spontaneous hepatitis in LEC rats. Mol Carcinog 1991;4:269-274.
48. Transy C, Fourel G, Robinson WS, Tiollais P, Marion PL, Buendia M-A. Frequent amplification of c-myc in ground squirrel liver tumors associated with past or ongoing infection with a hepadnavirus. Proc Natl Acad Sci USA 1992;89:3874-3878.
49. Pascale RM, de Miglio MR, Muroni MR, et al. c-myc Amplification in pre-malignant and malignant lesions induced in rat liver by the resistant hepatocyte model. Int J Cancer 1996;68:136-142.
50. Kawate S, Fukusato T, Ohwada S, Watanuki A, Morishita Y. Amplification of c-myc in helpatocellular carcinoma: Correlation with clinicopathologic features, proliferative activity, and p53 overexpression. Oncology 1999;57:157-163.
51. Alexandre K, Jacobovitz D, Galand P. Immunohistochemical detection of c-myc and c-erbA products in diethylnitrosamine-induced preneoplastic and neoplastic liver lesions in rats. Carcinogenesis 1990;11:1189-1194.
52. Hällström IP, Gustafsson J-Å, Blanck A. Role of growth hormone in the regulation of the c-myc gene during progression of sex-differentiated rat liver carcinogenesis in the resistant hepatocyte model. Mol Carcinog 1991;4:376-381.
53. UCSC Rat Genome Browser Gateway. URL: http://genome. ucsc.edu/cgi-bin/ hgGateway.
54. NCBI Sequence Viewer. NW_043402 Rattus norvegicus... [qi: 26007242]. URL: http://www.ncbi.nlm.nih.gov/ entrez.
55. Bremner R, Kemp CJ, Balmain A. Induction of different genetic changes by different classes of chemical carcinogens during progression of mouse skin tumors. Mol Carcinog 1994;11:90-97.
56. Meloni AM, Bridge J, Sandberg AA. Reviews on chromosome studies in urological tumors. I. Renal tumors. J Urol 1992;148:253-265.
57. Shiraishi M, Morinaga S, Noguchi M, Shimosato Y, Sekiya T. Loss of genes on the short arm of chromosome 11 in human lung carcinomas. Jpn J Cancer Res 1987;78:1302-1308.
58. Pachnis V, Brannan C, Tilghman S. The structure and expression of a novel gene activated in early mouse embryogenesis. EMBO J 1988;7:673-681.
59. Porier F, Chan C, Timmons P, Robertson E. The murine H19 gene is activated during embryonic stem cell differentiation in vitro and at the time of implantation in the developing embryo. Development 1991;113:1105-1114.
60. Hao Y, Crenshaw T, Moulton T, Newcomb E, Tycko B. Tumor suppressor activity of H19 RNA. Nature 1993;365:764-767.
61. Ariel I, Ayesh S, Perlman EJ, et al. The product of the imprinted H19 gene is an oncofetal RNA. Mol Pathol 1997;50:34-44.
62. Looijenga LHJ, Verkerk AJMH, De Groot N, Hochberg AA, Oosterhuis JW. H19 in normal development and neoplasia. Mol Reprod Dev 1997;46:419-439.
63. Douc-Rasy S, Coll J, Barrois M, et al. Expression of the human fetal BAC/H19 gene in invasive cancers. Int J Oncol 1993;2:753-758.
64. Manoharan H, Babcock K, Willi J, Pitot HC. Biallelic expression of the H19 gene during spontaneous hepatocarcinogenesis in the albumin SV40 T antigen transgenic rat. Mol Carcinog 2003;38:40-47.
65. Lottin S, Adriaenssens E, Dupressoir T, et al. Overexpression of an ectopic H19 gene enhances the tumorigenic properties of breast cancer cells. Carcinogenesis 2002;23:1885-1895.
66. Ayesh S, Matouk I, Schneider T, et al. Possible physiological role of the H19 RNA. Mol Carcinog 2002;35:63-74.
67. Vernucci M, Cerrato F, Besnard N, et al. The H19 endodermal enhancer is required for Igf2 activation and tumor formation in experimental liver carcinogenesis. Oncogene 2000;19:6376-6385.
68. Yang D, Rogler C. Analysis of insulin-like growth factor II (IGFII) expression in neoplastic nodules and hepatocellular carcinomas of woodchucks utilizing in situ hybridization and immunohistochemistry. Carcinogenesis 1991;12:1893-1901.
69. Christofori G, Naik P, Hanahan D. A second signal supplied by insulin-like growth factor II in oncogene induced tumorigenesis. Nature 1994;369:414-418.
70. Schirmacker A, Held W, Yang D, Chisari F, Rutsum Y, Rogler C. Reactivation of insulin-like growth factor II during hepatocarcinogenesis in transgenic mice suggests a role in malignant growth. Cancer Res 1992;52:2549-2556.
71. Takagi H, Sharp R, Takayama H, Anver M, Ward J, Merlino G. Collaboration between growth factors and diverse chemical carcinogens in hepatocarcinogenesis of transforming growth factor α transgenic mice. Cancer Res 1993;53:4329-4336.
72. Scharf J-G, Dombroski F, Ramadori G. The IGF axis and hepatocarcinogenesis J Clin Pathol: Mol Pathol 2001;54:138-144.
73. Ueno T, Takahashi K, Matsuguchi T, Ikejiri K, Endo H, Yamamoto M. Reactivation of rat insulin-like growth factor II gene during hepatocarcinogenesis. Carcinogenesis 1988;9:1779-1783.
74. Kim K-S, Lee Y-I. Biallelic expression of the H19 and IGF2 genes in hepatocellular carcinoma. Cancer Lett 1997;119:143-148.
75. Leighton P, Saam J, Ingram R, Stewart C, Tilghman SM. An enhancer deletion affects both H19 and Igf2 expression. Genes Dev 1995;9:2079-2089.
76. Leighton P, Ingram R, Eggenschwiller J, Efstratiadis A, Tilghman SM. Disruption of imprinting caused by deletion of the H19 gene region in mice. Nature 1995;375:34-39.
77. Gloudemans T, Popiech I, Van Der Ven L, et al. Expression of CpG methylation of the insulin-like growth factor II gene in human smooth muscle tumors. Cancer Res 1992;52:6516-6521.
78. Schneid H, Seurin D, Vazquez M, Gourmelen M, Cabrol S, Le Bouc Y. Parental allele specific methylation of the human insulin-like growth factor II gene and Beckwith-Wiedemann. J Med Genet 1993;30:353-362.
79. Rainier S, Dobry CJ, Feinberg AP. Loss of imprinting in hepatoblastoma. Cancer Res 1995;55:1836-1838.
80. Haddad R, Held WA. Genomic imprinting and Igf2 influence liver tumorigenesis and loss of heterozygosity in SV40 T antigen transgenic mice. Cancer Res 1997;57:4615-4623.
81. Casola S, Ungaro P, Pedone P, et al. Loss of heterozygosity of imprinted genes in SV40 t/T antigen-induced hepatocellular carcinomas. Oncogene 1995;11:712-721.
82. Lahm H, Gittner K, Krebs O, et al. Diethylnitrosamine induces long-lasting re-expression of insulin-like growth factor II during early stages of liver carcinogenesis in mice. Growth Horm IGF Res 2002;12:69-79.